Omicron, the latest SARS-CoV-2 Variant of Concern (VOC), first appeared in Africa in November 2021. At present, the question of whether a new VOC will out-compete the currently predominant variant is important for governments seeking to determine if current surveillance strategies and responses are appropriate and reasonable. Based on both virus genomes and daily-confirmed cases, we compare the additive differences in growth rates and reproductive numbers (R0) between VOCs and their predominant variants through a Bayesian framework and phylo-dynamics analysis. Faced with different variants, we evaluate the effects of current policies and vaccinations against VOCs and predominant variants. The model also predicts the date on which a VOC may ...
The Omicron variant spreads fastest as ever among the severe acute respiratory syndrome coronaviruse...
Vaccination and disease The United Kingdom has high rates of vaccination for ...
Abstract Background and Aim Understanding the prevalence and impact of SARS‐CoV‐2 variants has assum...
International audienceBackground: SARS-CoV-2 is a rapidly spreading disease affecting human life and...
Background: SARS-CoV-2 variants of concern, such as Omicron (B.1.1.529), continue to emerge. Assessi...
Since the start of the SARS-CoV-2 pandemic in late 2019, several variants of concern (VOC) have been...
International audienceWe read with interest the letter published recently by Costa et al. in the jou...
Genetic variants of severe acute respiratory syndrome coronavirus (SARS-CoV-2) have been globally su...
The English SARS-CoV-2 epidemic has been affected by the emergence of new viral variants such as B.1...
Since November 2019, SARS-CoV-2 has been a matter of global concern due to its rapid spread, the mil...
Almost three years have passed since the start of the COVID-19 pandemic. The severe acute respirator...
UK variant transmission Severe acute respiratory syndrome coronavirus 2 (SARS...
Background: Since its emergence in Autumn 2020, the SARS-CoV-2 Variant of Concern (VOC) B.1.1.7 (WHO...
Background In May, 2021, the delta (B.1.617.2) SARS-CoV-2 variant became dominant in the UK, superse...
Background: Since its emergence in Autumn 2020, the SARS-CoV-2 Variant of Concern (VOC) B.1.1.7 (WHO...
The Omicron variant spreads fastest as ever among the severe acute respiratory syndrome coronaviruse...
Vaccination and disease The United Kingdom has high rates of vaccination for ...
Abstract Background and Aim Understanding the prevalence and impact of SARS‐CoV‐2 variants has assum...
International audienceBackground: SARS-CoV-2 is a rapidly spreading disease affecting human life and...
Background: SARS-CoV-2 variants of concern, such as Omicron (B.1.1.529), continue to emerge. Assessi...
Since the start of the SARS-CoV-2 pandemic in late 2019, several variants of concern (VOC) have been...
International audienceWe read with interest the letter published recently by Costa et al. in the jou...
Genetic variants of severe acute respiratory syndrome coronavirus (SARS-CoV-2) have been globally su...
The English SARS-CoV-2 epidemic has been affected by the emergence of new viral variants such as B.1...
Since November 2019, SARS-CoV-2 has been a matter of global concern due to its rapid spread, the mil...
Almost three years have passed since the start of the COVID-19 pandemic. The severe acute respirator...
UK variant transmission Severe acute respiratory syndrome coronavirus 2 (SARS...
Background: Since its emergence in Autumn 2020, the SARS-CoV-2 Variant of Concern (VOC) B.1.1.7 (WHO...
Background In May, 2021, the delta (B.1.617.2) SARS-CoV-2 variant became dominant in the UK, superse...
Background: Since its emergence in Autumn 2020, the SARS-CoV-2 Variant of Concern (VOC) B.1.1.7 (WHO...
The Omicron variant spreads fastest as ever among the severe acute respiratory syndrome coronaviruse...
Vaccination and disease The United Kingdom has high rates of vaccination for ...
Abstract Background and Aim Understanding the prevalence and impact of SARS‐CoV‐2 variants has assum...